HALOZYME THERAPEUTICS INC (HALO) Institutional Ownership

HALO is currently held by 3 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $50.03M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $47.30M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's HALO position is now estimated to be worth approximately $52.07M, representing an estimated gain of +10.09% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, Torray Fund, Hancock Classic Value, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks asset manager ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward HALOZYME THERAPEUTICS INC (HALO).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20263$50,026,141774,039
Q4 20254$41,071,305610,272
Q3 20254$76,740,9961,046,373
Q2 20252$19,697,737378,657
Q1 20252$11,191,891175,394
Q4 20242$3,907,08181,721
Q3 20242$17,775,195310,538
Q2 20242$22,427,254428,328
Q1 20242$1,952,819535,896
Q4 20232$1,481,334233,266
Q3 20232$997,428131,685
Q2 20232$901,50059,039